Kalaris Therapeutics (KLRS) Operating Leases (2019 - 2020)
Kalaris Therapeutics (KLRS) has 2 years of Operating Leases data on record, last reported at $6.3 million in Q3 2020.
- For Q3 2020, Operating Leases changed N/A year-over-year to $6.3 million; the TTM value through Sep 2020 reached $6.3 million, changed N/A, while the annual FY2019 figure was $8.7 million, N/A changed from the prior year.
- Operating Leases reached $6.3 million in Q3 2020 per KLRS's latest filing, down from $7.1 million in the prior quarter.
- Across five years, Operating Leases topped out at $8.7 million in Q4 2019 and bottomed at $6.3 million in Q3 2020.